- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07755358
Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance and Passing Performance in Adolescent Soccer Players
Effects of an Eight-Week Small-Sided Games Training Program on Aerobic Endurance and Passing Performance in Adolescent Soccer Players: A Randomized Controlled Trial
Soccer requires players to combine physical fitness with technical skills throughout a match. Small-sided games (SSG) are modified soccer training sessions played with fewer players and reduced pitch dimensions. These training formats are widely used because they simulate match situations while providing high physical and technical demands.
The purpose of this randomized controlled trial was to investigate whether an eight-week SSG training program improves aerobic endurance and passing performance in adolescent male soccer players. Eighteen licensed youth soccer players were randomly assigned to either an SSG training group or a control group. Both groups continued their regular soccer training, while the SSG group additionally performed structured small-sided game sessions three times per week for eight weeks.
Aerobic endurance was evaluated using the Yo-Yo Intermittent Recovery Test Level 1 (Yo-Yo IR1), and passing performance was assessed using the Loughborough Soccer Passing Test (LSPT). These measurements were obtained before and after the intervention.
The primary objective of the study was to compare changes in aerobic endurance and passing performance between the SSG and control groups. It was hypothesized that participation in the structured SSG program would result in greater improvements in both outcomes compared with regular soccer training alone.
The findings of this study are expected to provide evidence supporting the use of structured small-sided games as an effective and time-efficient training strategy for improving both physical fitness and technical performance in adolescent soccer players.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Istanbul
-
Istanbul, Istanbul, Turkey (Türkiye), 34290
- Istanbul Gelisim University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male soccer players aged 17 to 18 years.
- Licensed amateur soccer players with at least five years of organized soccer experience.
- Regular participation in team training sessions.
- No serious musculoskeletal injury within the previous six months.
- No chronic neurological, cardiovascular, or musculoskeletal conditions that could affect participation or performance.
- Provided written informed consent (and parental/legal guardian consent where applicable).
Exclusion Criteria:
- Serious musculoskeletal injury during the study period.
- Absence from more than two scheduled training sessions.
- Voluntary withdrawal from the study at any time.
- Failure to complete the pre-intervention or post-intervention outcome assessments.
- Any medical condition preventing safe participation in high-intensity soccer training.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Small-Sided Games (SSG) Training
Participants continued their regular soccer training and additionally completed a structured small-sided games (SSG) training program three times per week for eight weeks.
The intervention included progressively modified 2v2, 3v3, and 4v4 game formats with varying pitch dimensions and tactical constraints designed to improve aerobic endurance and passing performance.
|
Participants performed structured small-sided games (SSG) training three times per week for eight weeks in addition to their regular soccer training.
The intervention included 2v2, 3v3, and 4v4 game formats with progressively modified pitch dimensions and tactical constraints to improve aerobic endurance and passing performance.
|
|
Active Comparator: Regular Soccer Training (Control)
Participants continued their regular soccer training program without additional structured small-sided games training throughout the eight-week study period.
|
Participants continued their routine soccer training program without exposure to structured small-sided games during the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Aerobic Endurance (Yo-Yo Intermittent Recovery Test Level 1 Distance)
Time Frame: Baseline and Week 8
|
Aerobic endurance was assessed using the Yo-Yo Intermittent Recovery Test Level 1 (Yo-Yo IR1).
The primary outcome was the total distance covered (meters) during the test.
Higher values indicate better aerobic endurance.
|
Baseline and Week 8
|
|
Passing Performance (Loughborough Soccer Passing Test)
Time Frame: Baseline and Week 8
|
Passing performance was evaluated using the Loughborough Soccer Passing Test (LSPT).
The primary outcome was the total test completion time (seconds), including penalty time.
Lower values indicate better passing performance.
|
Baseline and Week 8
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SSG-YSP-2025-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.